| Literature DB >> 34792224 |
Katharina Bleher1, Peter Comba1, Dieter Faltermeier1, Ashutosh Gupta1, Marion Kerscher1, Saskia Krieg1, Bodo Martin1, Gunasekaran Velmurugan1, Shuyi Yang1.
Abstract
Oxidation of the iron(II) precursor [(L1 )FeII Cl2 ], where L1 is a tetradentate bispidine, with soluble iodosylbenzene (s PhIO) leads to the extremely reactive ferryl oxidant [(L1 )(Cl)FeIV =O]+ with a cis disposition of the chlorido and oxido coligands, as observed in non-heme halogenase enzymes. Experimental data indicate that, with cyclohexane as substrate, there is selective formation of chlorocyclohexane, the halogenation being initiated by C-H abstraction and the result of a rebound of the ensuing radical to an iron-bound Cl- . The time-resolved formation of the halogenation product indicates that this primarily results from s PhIO oxidation of an initially formed oxido-bridged diiron(III) resting state. The high yield of up to >70 % (stoichiometric reaction) as well as the differing reactivities of free Fe2+ and Fe3+ in comparison with [(L1 )FeII Cl2 ] indicate a high complex stability of the bispidine-iron complexes. DFT analysis shows that, due to a large driving force and small triplet-quintet gap, [(L1 )(Cl)FeIV =O]+ is the most reactive small-molecule halogenase model, that the FeIII /radical rebound intermediate has a relatively long lifetime (as supported by experimentally observed cage escape), and that this intermediate has, as observed experimentally, a lower energy barrier to the halogenation than the hydroxylation product; this is shown to primarily be due to steric effects.Entities:
Keywords: C−H activation; DFT calculations; biomimetic coordination chemistry; non-heme-iron; reaction mechanism
Mesh:
Substances:
Year: 2021 PMID: 34792224 PMCID: PMC9300152 DOI: 10.1002/chem.202103452
Source DB: PubMed Journal: Chemistry ISSN: 0947-6539 Impact factor: 5.020
Scheme 1The non‐heme‐iron halogenase mechanism, ligands discussed and structure of the bispidine‐iron(IV)‐oxido‐chlorido complex with the tetradentate bispidine L1.
Reported halogenation versus hydroxylation selectivities of the non‐heme‐iron model systems [(L )(Cl)FeIV=O]+ (n=1, 4, 5, 6).
|
Ligand |
Formation of [(L
|
% R−Cl |
% R−OH |
% R=O |
Ref. |
|---|---|---|---|---|---|
|
L1 |
oxidation, sPhIO |
100 |
0 |
0 |
|
|
L4 |
ligand exchange[a] |
78 |
15 |
7 |
|
|
L5 |
[a] or oxidation, TBHP |
85 |
0 |
15 |
[ |
|
L6 |
ligand exchange[a] |
0 |
–[b] |
–[b] |
|
[a] Produced by exchange of MeCN with Cl− at the [(L )(MeCN)FeIV=O]2+ precursor. [b] Not reported.
Scheme 2Proposed mechanism of oxidation with high‐valent iron−bispidine complexes.
Figure 1Comparison of the time‐dependent formation of chlorocyclohexane with [(L1)(Cl)FeIV=O]+ (•) and FeCl2 (•).
Yield of products obtained in the reaction of [(L1)(Cl)FeIV=O]+, [(L2)(Cl)FeIV=O]+ and {(L3)[(Cl)FeIII]2O}2+ under standard conditions, where not indicated otherwise (1 equiv., 7 mM) with sPhIO (10 equiv.) and cyclohexane (100 equiv.) in MeCN after stirring for 24 h under Ar at ambient temperature. Percentages are based on the amount of FeII complex used.
|
Complex |
Salt (conc. in MeCN) |
C6H11Cl [%] |
|---|---|---|
|
[(L1)(Cl)FeIV=O]+ |
– |
47.0±4.3 |
|
[(L1)(Cl)FeIV=O]+ |
NBu4PF6 (700 mM) |
50.4±3.6 |
|
[(L1)(Cl)FeIV=O]+ |
NBu4Cl (700 mM) |
14.4±2.1 |
|
[(L1)(Cl)FeIV=O]+ |
NBu4Cl (70 mM) |
29.6 |
|
[(L1)(Cl)FeIV=O]+ |
– |
0.8±0.2[a] |
|
[(L1)(Cl)FeIV=O]+ |
NBu4Cl (100 mM) |
1.1±0.1[a] |
|
[(L1)(Cl)FeIV=O]+ |
NBu4PF6 (100 mM) |
1.2±0.2[a] |
|
[(L2)(Cl)FeIV=O]+ |
– |
73.6±3.2 |
|
{(L3)[(Cl)FeIII]2O}2+ |
– |
39.8 |
[a] With 1 instead of 10 equiv. of sPhIO, i. e., stoichiometric reaction.
Comparison of the percentage yields of the products obtained in the reaction of [(L1)(Cl)FeIV=O]+, [(L2)(Cl)FeIV=O]+, FeCl2 and FeCl3 (1 equiv. each) with sPhIO (10 equiv.) and cyclopentane, cyclohexane (100 equiv.) or adamantane (10 equiv.) in abs. MeCN after stirring for 24 h at ambient temperature. The percentage yields refer to the amount of iron(II) complex used.
|
Substrate |
Products |
[(L1)(Cl)FeIV=O]+ |
[(L2)(Cl)Fei |
FeCl2 |
FeCl3 |
|---|---|---|---|---|---|
|
cyclohexane |
chlorocyclohexane |
47.0±4.3 |
73.6±3.2 |
33.7±3.5 |
39.5±7.0 |
|
cyclopentane |
chlorocyclopentane |
40.1±7.3 |
73.7±5.9 |
25.3±6.3 |
41.8±0.3 |
|
adamantane |
1‐chloroadamantane |
23.6±1.4 |
66.9±4.7 |
28.9±1.9 |
21.5±2.9 |
|
2‐chloroadamantane |
5.9±0.3 |
17.5±0.8 |
10.6±0.9 |
10.0±1.3 | |
|
adamantane‐1‐ol |
4.2±0.6 |
0 |
0.8±0.1 |
0 | |
|
adamantane‐2‐ol |
0.6±0.1 |
1.9±0.4 |
0 |
0 |
Figure 2Computed profile for the reaction of [(L1)(Cl)FeIV=O]+ (O trans N3) with cyclohexane at the UB3LYP/def2TZVP level (PCM/MeCN).
Figure 3Computed reaction profile (UB3LYP/def2TZVP level; PCM/ MeCN) for the abstraction of C−H from cyclohexane with [(L1)(Cl)FeIV=O]+, [(L4)(Cl)FeIV=O]+, [(L5)(Cl)FeIV=O]+ and [(L6)(Cl)FeIV=O]+ on the quintet surface, where all reactant energies have been set to 0.0 kJ mol−1.
Figure 4Computed reaction profile (UB3LYP/def2TZVP level; PCM/MeCN) for the hydroxylation (left) vs. halogenation (right) of [(L1)(Cl)FeIV=O]+, [(L4)(Cl)FeIV=O]+, [(L5)(Cl)FeIV=O]+ and [(L6)(Cl)FeIV=O]+ with cyclohexane. the rebound part of the reaction is shown, starting with the LFeIII(OH)(Cl)+/cyclohexyl radical intermediate set to 0.0 kJ mol−1. A full reaction profile for [(L1)(Cl)FeIV=O]+ is given in the Supporting Information.